Despite the ASX200 trading flat today, certain sectors like Real Estate and Financials have shown resilience, while others such as Energy and IT faced challenges. In this mixed market environment, growth companies with high insider ownership can offer unique insights into potential opportunities, as they often indicate strong confidence from those closest to the business.
Top 10 Growth Companies With High Insider Ownership In Australia
| Name | Insider Ownership | Earnings Growth |
| Wisr (ASX:WZR) | 15% | 92.8% |
| Newfield Resources (ASX:NWF) | 31.5% | 72.1% |
| IperionX (ASX:IPX) | 18.7% | 59.1% |
| Image Resources (ASX:IMA) | 22.3% | 79.8% |
| Gratifii (ASX:GTI) | 17.8% | 114.0% |
| Findi (ASX:FND) | 33.6% | 91.2% |
| Echo IQ (ASX:EIQ) | 18% | 51.4% |
| BlinkLab (ASX:BB1) | 39.8% | 52.7% |
| Adveritas (ASX:AV1) | 18.1% | 80.7% |
| Acrux (ASX:ACR) | 15.5% | 106.9% |
We're going to check out a few of the best picks from our screener tool.
Meeka Metals (ASX:MEK)
Simply Wall St Growth Rating: ★★★★★★
Overview: Meeka Metals Limited is involved in the exploration and development of gold properties in Western Australia, with a market cap of A$422.78 million.
Operations: Meeka Metals Limited's revenue segments are not specified in the provided text.
Insider Ownership: 12%
Meeka Metals is positioned for substantial growth, with earnings projected to increase 63.25% annually and revenue expected to grow at 58.8% per year, outpacing the market. Despite recent shareholder dilution from a A$60 million equity offering, it trades significantly below its estimated fair value. The company is actively expanding its gold production capabilities through strategic acquisitions and development of its Murchison Gold Project in Western Australia, although a recent buyout proposal for New Murchison was declined.
- Delve into the full analysis future growth report here for a deeper understanding of Meeka Metals.
- Upon reviewing our latest valuation report, Meeka Metals' share price might be too optimistic.
PYC Therapeutics (ASX:PYC)
Simply Wall St Growth Rating: ★★★★★☆
Overview: PYC Therapeutics Limited is an Australian drug-development company focused on discovering and developing novel RNA therapeutics for genetic diseases, with a market cap of A$752.41 million.
Operations: The company's revenue is primarily derived from its activities in the discovery and development of novel RNA therapeutics, amounting to A$24.99 million.
Insider Ownership: 35.9%
PYC Therapeutics is projected to achieve significant earnings growth of 25.67% annually and is expected to become profitable within three years, outpacing average market growth. Although revenue is forecasted to grow at 13.2% per year, which surpasses the Australian market rate, the company reported a net loss of A$50.3 million for FY2025. Trading at a substantial discount to its estimated fair value, PYC has experienced shareholder dilution over the past year.
- Click to explore a detailed breakdown of our findings in PYC Therapeutics' earnings growth report.
- Our comprehensive valuation report raises the possibility that PYC Therapeutics is priced higher than what may be justified by its financials.
Technology One (ASX:TNE)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Technology One Limited develops, markets, sells, implements, and supports integrated enterprise business software solutions in Australia and internationally, with a market cap of A$12.84 billion.
Operations: The company's revenue segments include Software generating A$378.25 million, Corporate contributing A$90.55 million, and Consulting bringing in A$82.87 million.
Insider Ownership: 10.4%
Technology One is forecasted to achieve earnings growth of 16.65% annually, surpassing the Australian market's average. While revenue growth is expected at 13.2% per year, it remains below the high-growth threshold of 20%. The stock trades at a significant discount to its estimated fair value and boasts a robust projected Return on Equity of 35.2% in three years. Recent leadership changes include the appointment of Matthew Thompson as Company Secretary, enhancing governance expertise.
- Click here to discover the nuances of Technology One with our detailed analytical future growth report.
- Our valuation report here indicates Technology One may be overvalued.
Turning Ideas Into Actions
- Investigate our full lineup of 100 Fast Growing ASX Companies With High Insider Ownership right here.
- Searching for a Fresh Perspective? These 13 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Valuation is complex, but we're here to simplify it.
Discover if Meeka Metals might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com